Reporting Manager
Soleus Capital Master Fund, L.P.
Symbol
CCCC
Shares outstanding
103,722,322 shares
Disclosed Ownership
10,361,860 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 17:02:01 UTC
Date of event
31 Dec 2025

Sponsored

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 10% ownership in C4 Therapeutics, Inc Common Stock, par value $0.0001 per share (CCCC) on 31 Dec 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for C4 Therapeutics, Inc Common Stock, par value $0.0001 per share (CCCC).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2026, 17:02.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (9)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Private Equity Fund III, L.P. 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus Private Equity GP III, LLC 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus PE GP III, LLC 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Master Fund, L.P. 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy